Nexelis is your partner for assay and biomarker development, advanced bioanalytical and laboratory testing, and translational immunology. As the leading specialty laboratory, we have unrivaled expertise in immunology, specifically in the areas of infectious diseases, vaccine development, metabolic diseases, and immuno-oncology. Vast experience, scientific discipline, and operational agility make Nexelis the partner to advance your molecule to market faster. Our deep bench of scientists, advanced technology platforms, and international network of laboratories provide the biopharmaceutical industry with translational solutions from discovery through late stage clinical development. Nexelis is instrumental in the development and large-scale sample testing for new modalities. These future therapies include blockbuster vaccines and biologics, antiviral drugs, immunotherapies, and gene and cell therapy products.
When you need a partner to navigate therapeutic development, advance programs, and consistently generate high-quality data, choose Nexelis.
- As CEO, it’s my privilege to introduce you to Nexelis, a unique balance of world-class standards and human-scale collaboration.
- As a state-of-the-art CRO, we place scientific discipline at the heart of every project, aided by our advanced facilities and cutting-edge technology.
- Yet one of our key advantages is agility, an abundance of critical thinking from open minds in order to compress time and achieve results.
- That’s why there’s no overlong process or heavy hierarchy. Instead, we encourage our specialists to exchange freely with colleagues and partner with clients in a spirit of friendship and transparency.
- All-in-all, we at Nexelis offer a distinctive approach that generates enthusiasm from our scientists, collaborators as well as from our clients.
- On behalf of all of us, thank you for your interest. To discover how our fit-for-purpose services and accelerated capabilities can answer your specific requirements, I invite you to contact us directly.